Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries posted a 21.3% rise in net profit for the third fiscal quarter (Q3) ended 31October, reaching EGP 21.1 million ($2.7 million) compared with EGP 17.4 million ($2.2 million) in the same period last year.
The company’s revenues reached EGP 150.9 million for the period, compared to EGP 138.8 million in 2014, according to the company’s financial statements.
In the second fiscal quarter ended in 30 September, the drug firm saw a profit of EGP 16.14 million, as compared with EGP 13.31 million in the same period a year ago.
